cms_DE: 6
In collaboration with The Seattle Times, Big Local News is providing full-text nursing home deficiencies from Centers for Medicare & Medicaid Services (CMS). These files contain the full narrative details of each nursing home deficiency cited regulators. The files include deficiencies from Standard Surveys (routine inspections) and from Complaint Surveys. Complete data begins January 2011 (although some earlier inspections do show up). Individual states are provides as CSV files. A very large (4.5GB) national file is also provided as a zipped archive. New data will be updated on a monthly basis. For additional documentation, please see the README.
This data as json, copyable
|
rowid
|
facility_name
|
facility_id
|
address
|
city
|
state
|
zip
|
inspection_date
|
deficiency_tag
|
scope_severity
|
complaint
|
standard
|
eventid
|
inspection_text
|
filedate
|
| 6 |
KENTMERE REHABILITATION AND HEALTHCARE CENTER |
85001 |
1900 LOVERING AVENUE |
WILMINGTON |
DE |
19806 |
2016-07-18 |
428 |
D |
0 |
1 |
Z68211 |
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on record reviews and interview, it was determined that the monthly MRR, completed by the consultant pharmacist, failed to identify the lack of monitoring of efficacy of Pravastatin for two (R126 and R112) out of 30 Stage 2 sampled residents. Findings include: The product information for Pravastatin, last revised 7/2016, stated, . Adult Patients . Since maximal effect of a given dose is seen within 4 weeks, periodic lipid determinations should be performed at this time and dosage adjusted according to the patient's response to therapy and established treatment guidelines . Cross refer to F329, example 1 1. Review of R126's clinical record revealed: R126 had a physician's orders [REDACTED]. Review of R126's pharmacy reviews from (MONTH) (YEAR) to (MONTH) (YEAR) revealed the consultant pharmacist's failure to identify that R126 was not getting lipid determinations performed periodically as indicated while taking Pravastatin. In an interview on 7/14/16 at 11:15 AM, E5 (LPN, UM) confirmed the finding. Findings were reviewed with E2 (DON) on 7/18/16 at 10:10 AM. Cross refer to F329, example 2 2. Review of R112's clinical record revealed: R112 had a physician's orders [REDACTED]. Review of R112's pharmacy reviews from (MONTH) (YEAR) to (MONTH) (YEAR) revealed the consultant pharmacist's failure to identify that R112 was not getting lipid determinations performed periodically as indicated while taking Pravastatin. In an interview on 7/15/16 at 3:32 PM, E5 confirmed the finding. Findings were reviewed with E2 (DON) on 7/18/16 at 10:10 AM. |
2020-09-01 |